Evidence map›Paper›PMID 39493139›Full record

ArticleCureus2024

Congenital Mesoblastic Nephroma Mixed Subtype: A Case Report of a Rare Neonatal Tumor.

Mohammed Alpakra, Sara S Hassanien, Badriah G Alasmari, Abdelhakam A Elmugadam, Ali M Tahir, Mohammed Beaiti, Omar Safar, Mohamed F Bazeed, Mahmoud Hussein

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammed AlpakraDepartment of Oncology and Hematology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Sara S HassanienDepartment of Pediatric Hematology/Oncology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Badriah G AlasmariDepartment of Pediatrics, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Abdelhakam A ElmugadamDepartment of Pediatric Hematology/Oncology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Ali M TahirDepartment of Pediatrics, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Mohammed BeaitiDepartment of Urology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Omar SafarDepartment of Urology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Mohamed F BazeedDepartment of Radiology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Mahmoud HusseinDepartment of Pathology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital renal tumors are rare. In infancy, congenital mesoblastic nephroma is the most commonly reported renal tumor. It is recognized antenatally due to polyhydramnios and presents clinically as a palpable abdominal mass in the neonatal period. Although widely regarded as a benign tumor, radical nephrectomy is routinely adopted as an effective treatment. We report a case involving antenatal recognition of a large fetal renal mass with polyhydramnios at 35 weeks of gestation. At 37 weeks of gestation, the baby was delivered via emergency cesarean section due to fetal distress. After delivery, a magnetic resonance imaging scan confirmed a solid mass in the left kidney, and a left radical nephrectomy was performed in the second week of life. The subsequent pathological examination confirmed a mixed (cellular and classical) variant of congenital mesoblastic nephroma.

Indexed as

antenatal detectioncongenital mesoblastic nephromafetal tumorsmagnetic resonance imagingrenal tumor

Identifiers

PMID39493139
PMCPMC11529903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.